SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies

Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
doi: https://doi.org/10.1101/2022.04.12.22273675

Data Availability

All sequence data (cleaned of human reads) are available on NCBI under BioProject PRJNA634356. SARS-CoV-2 consensus sequences are available in GISAID under accession numbers EPI_ISL_1503958 and EPI_ISL_6913932-43.

Back to top
Posted April 19, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
medRxiv 2022.04.12.22273675; doi: https://doi.org/10.1101/2022.04.12.22273675
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area